Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors

Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?

(2012) Michel Azizi et al.   CARDIOVASCULAR DRUGS AND THERAPY

The intracrine renin–angiotensin system

(2012) Rajesh Kumar et al.   CLINICAL SCIENCE

Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor

(2012) Candice M. Thomas et al.   CLINICAL SCIENCE

Association of Weight Status With Mortality in Adults With Incident Diabetes

(2012) Mercedes R. Carnethon et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin–angiotensin system activity in obese hypertensive patients

(2012) Michael Boschmann et al.   JOURNAL OF HYPERTENSION

Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes

(2011) Misaki Iwashita et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Review: Novel roles of nuclear angiotensin receptors and signaling mechanisms

(2011) TanYa M. Gwathmey et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Review: Intracardiac intracellular angiotensin system in diabetes

(2011) Rajesh Kumar et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Review: Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model

(2011) Julia L. Cook et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

(2011) Yumei Ye et al.   CARDIOVASCULAR DRUGS AND THERAPY

Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1 - connective tissue growth factor signalling cascade

(2011) Jiqian Huang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart

(2011) Duncan J Campbell et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts

(2010) J. H. M. van Esch et al.   CARDIOVASCULAR RESEARCH

Angiotensin I–Converting Enzyme Inhibitors Are Allosteric Enhancers of Kinin B1 and B2 Receptor Function

(2010) Ervin G. Erdös et al.   HYPERTENSION

Nuclear-delimited Angiotensin Receptor-mediated Signaling Regulates Cardiomyocyte Gene Expression

(2010) Artavazd Tadevosyan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Contribution of Bradykinin B2 Receptors to the Inhibition by Valsartan of Systemic and Renal Effects of Exogenous Angiotensin II in Salt-Repleted Humans

(2010) A. Biggi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Development of Heart Failure in Patients With Diabetes Mellitus and Pre-Clinical Diastolic Dysfunction

(2010) Aaron M. From et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy

(2009) D. Westermann et al.   DIABETES

Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production

(2008) Vivek P. Singh et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis

(2008) V. P. Singh et al.   DIABETES

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

(2008) David L. Feldman et al.   HYPERTENSION